To assess our clinical ability to predict prostate involvement by transitional cell carcinoma (PI-TCC) or occult prostate cancer (CAP) in patients undergoing radical cystectomy (RCx).
We retrospectively analyzed 70 male patients undergoing RCx for TCC of the bladder between 1995 and 2003, focusing on preoperative factors to predict PI-TCC or CAP.
Of 70 RCx patients, 30 (43%) had PI-TCC (14) or CAP (16). Risk factors for PI-TCC included carcinoma in situ, multifocal TCC, and bladder neck involvement (P <0.05 for all three analyses). All 14 patients with PI-TCC had one or more risk factors, and none of 40 patients without these risk factors had PI-TCC (P <0.001). Risk factors for CAP included elevated prostate-specific antigen level, abnormal results on digital rectal examination, and age more than 65 years. Of 16 patients with CAP, 14 had one or more of these risk factors (P <0.05). Sixteen of the seventy patients in this series (22.9%) had no risk factors for PI-TCC or CAP, and none of these had prostatic involvement with either malignancy (P <0.05).
Our findings suggest that a well-defined subset of patients undergoing RCx might be at low risk for malignancy in the prostate. However, further evaluation of these risk factors in a prospective setting will be required to substantiate these findings and guide clinical decision making in this controversial field.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Urology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Sexual rehabilitation and male radical cystectomy.J Urol. 1986; 136: 1015-1017
- Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit or cutaneous or urethral Koch pouch.J Urol. 1999; 162: 77-81
- Review of Mayo Clinic experience with carcinoma in situ.Urology. 1985; 26: 39-46
- The prostate involvement as prognostic factor in patients with superficial bladder tumors.J Urol. 1995; 154: 1710-1713
- Prostatic involvement by transitional cell carcinoma.J Urol. 1977; 118: 399-403
- Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.J Urol. 1989; 141: 346-349
- Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy.J Urol. 1992; 147: 92-95
- Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies.J Urol. 2004; 171: 646-651
- Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes.J Urol. 1989; 141: 1091-1094
- Incidence and histological findings of unsuspected prostate adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.Scand J Urol Nephrol. 1999; 33: 27-30
- Cystectomy with prostate sparing for bladder cancer in 100 patients.J Urol. 2002; 168: 2413-2417
- Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy.J Urol. 1999; 161: 1761-1764
- Experience with ‘capsule sparing’ cystoprostatectomy for orthotopic bladder replacement.BJU Int. 2002; 90: 617-620
- Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer.Cancer. 1993; 71: 933-938
- Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?.J Urol. 2001; 166: 1296-1299
- Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder.Semin Urol Oncol. 1997; 15: 154-160
- Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage.J Urol. 2003; 170: 1085-1087
- Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder.J Urol. 1998; 159: 792-795
- Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder.J Urol. 2002; 167: 502-505
- Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.Cancer. 1989; 63: 381-385
Accepted: July 6, 2005
Received: December 22, 2004
© 2005 Elsevier Inc. Published by Elsevier Inc. All rights reserved.